Anjali Agrawal

TL;DR: This review provides an updated overview of manufacturing techniques for preparing ASDs, and selection strategies are proposed to identify suitable manufacturing methods, which may aid in the development of ASDs with satisfactory physical stability.

TL;DR: This study provides a framework for developing low dose micro-tablets with acceptable quality attributes using HSWG process for micro-dosing, enhanced dose flexibility, and decreased excipient burden.

TL;DR: In this article, a novel use of nanocrystalline suspension combined with high shear wet granulation for the first time was presented, which resulted in excellent content uniformity among individual micro-tablets even at a dose strength as low as 0.16 mcg, whereas micronized drug resulted in unacceptable CU even at 5x higher dose strength (0.8 mcg).

TL;DR: In this paper, a workshop was organized by the European Paediatric Formulation Initiative (EuPFI) to reflect on the current scenario and the different practices employed by formulation scientists in the selection of excipients for paediatric formulations.

TL;DR: In this article, pharmaceutical compositions (eg, oral dosage formulations) comprising (S)-4-(4-( 4-(4-(((2-(2,6-dioxopiperidin-3-yl)-loxoisoindolin-4- yl)oxy)methyl)benzyl)piperazin-l-yl)3-fluorobenzonitrile, or an enantiomer, mixture of enantiomers, tautomer, isotopolog, or pharmaceutically acceptable salt thereof, and a carrier or